Tower Research Capital (TRC)’s SAB Biotherapeutics SABS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.27K | Buy |
726
+692
| +2,035% | +$1.21K | ﹤0.01% | 4837 |
|
|
2025
Q1 | $46 | Sell |
34
-808
| -96% | -$1.09K | ﹤0.01% | 5079 |
|
|
2024
Q4 | $3.2K | Sell |
842
-1,243
| -60% | -$4.72K | ﹤0.01% | 4693 |
|
|
2024
Q3 | $5.63K | Sell |
2,085
-308
| -13% | -$832 | ﹤0.01% | 4240 |
|
|
2024
Q2 | $7.42K | Buy |
2,393
+957
| +67% | +$2.97K | ﹤0.01% | 4468 |
|
|
2024
Q1 | $6.52K | Sell |
1,436
-88
| -6% | -$399 | ﹤0.01% | 4356 |
|
|
2023
Q4 | $10.5K | Buy |
1,524
+30
| +2% | +$206 | ﹤0.01% | 4240 |
|
|
2023
Q3 | $9.41K | Buy |
1,494
+39
| +3% | +$246 | ﹤0.01% | 4222 |
|
|
2023
Q2 | $12.1K | Sell |
1,455
-151
| -9% | -$1.25K | ﹤0.01% | 3881 |
|
|
2023
Q1 | $7K | Buy |
1,606
+465
| +41% | +$2.03K | ﹤0.01% | 4763 |
|
|
2022
Q4 | $7K | Sell |
1,141
-223
| -16% | -$1.37K | ﹤0.01% | 4613 |
|
|
2022
Q3 | $10K | Buy |
1,364
+546
| +67% | +$4K | ﹤0.01% | 4570 |
|
|
2022
Q2 | $12K | Buy |
818
+645
| +373% | +$9.46K | ﹤0.01% | 4305 |
|
|
2022
Q1 | $7K | Buy |
173
+16
| +10% | +$647 | ﹤0.01% | 4756 |
|
|
2021
Q4 | $12K | Buy |
+157
| New | +$12K | ﹤0.01% | 4322 |
|
|
2021
Q3 | – | Sell |
-9
| Closed | -$1K | – | 6117 |
|
|
2021
Q2 | $1K | Buy |
+9
| New | +$1K | ﹤0.01% | 5248 |
|